The Food and Drug Administration (FDA) is examining potential health concerns associated with a group of medications used for weight loss.
These include the likes of Ozempic, Wegovy, Mounjaro, and Zepbound. The FDA’s quarterly report revealed that the agency is investigating reports of alopecia (hair loss), aspiration during surgery, and suicidal ideation among individuals using these medications.
Ozempic, containing Semaglutide, was originally